TOT BIOPHARM International Company Limited (1875.HK)
HKD 1.65
(0.0%)
HKD 1.65
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 56.43 Million | 59.92 Million | -175.13 Million | -263.11 Million | -251.32 Million | -176.83 Million |
| Net Income | -37.75 Million | -50.04 Million | -261.21 Million | -288.49 Million | -299.3 Million | -268.26 Million |
| Depreciation & Amortization | 43.02 Million | 38.03 Million | 34.23 Million | 32.08 Million | 27.35 Million | 15.65 Million |
| Deferred income taxes | - | 7.34 Million | -4.17 Million | -2.56 Million | 26.12 Million | 25.51 Million |
| Stock-based compensation | 10.64 Million | 16.11 Million | 5.29 Million | 15.83 Million | 23.55 Million | 25.67 Million |
| Change in working capital | 11.72 Million | 44.14 Million | 49.22 Million | -19.79 Million | -29.55 Million | 22.9 Million |
| Other non-cash items | 2.2 Million | 4.33 Million | 1.49 Million | -174 Thousand | 494 Thousand | 1.67 Million |
| Investing Cash Flow | -164.1 Million | -282.76 Million | -108.39 Million | 12.52 Million | -51.1 Million | -47.06 Million |
| Investments in PPE | -203.2 Million | -240.12 Million | -115.31 Million | -22.18 Million | -37.34 Million | -78.19 Million |
| Acquisitions | -2.6 Million | -5.15 Million | -1.5 Million | -34.34 Million | 1.05 Million | 1.55 Million |
| Investment purchases | -280 Million | -255 Million | -6.9 Million | -365.57 Million | -131.8 Million | -116.5 Million |
| Sales/Maturities of investments | 321.21 Million | 215.63 Million | 8.4 Million | 399.91 Million | 118.01 Million | 147.63 Million |
| Other Investing Activities | 33.17 Million | 1.87 Million | 6.92 Million | 34.7 Million | -1.03 Million | -1.55 Million |
| Financing Cash Flow | 38.22 Million | 481.24 Million | 212.08 Million | -61.7 Million | 583.02 Million | 457.6 Million |
| Debt repayment | -56.65 Million | -196.19 Million | -1.49 Million | -60 Million | -500 Thousand | -68.19 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 405.78 Million | 1.99 Million | - | 541.95 Million | - |
| Other Financing Activities | -3.37 Million | 271.64 Million | 211.58 Million | -1.7 Million | 41.57 Million | 525.79 Million |
| Accounts receivables | -82.54 Million | -35.68 Million | -20.23 Million | 10.1 Million | -5.1 Million | -3.04 Million |
| Accounts payables | - | - | - | - | 5.1 Million | 3.04 Million |
| Inventory | -31.18 Million | -65.26 Million | -21.44 Million | 7.13 Million | -12.14 Million | -2.12 Million |
| Other working capital | 21.22 Million | 145.08 Million | 90.89 Million | -37.02 Million | -17.4 Million | 25.03 Million |
| Cash at beginning of period | 417.76 Million | 152.8 Million | 225.53 Million | 539.18 Million | 256.75 Million | 24.58 Million |
| Cash at end of period | 351.6 Million | 417.76 Million | 152.8 Million | 225.53 Million | 539.18 Million | 256.75 Million |
| Capital Expenditure | -203.2 Million | -240.12 Million | -115.31 Million | -22.18 Million | -37.34 Million | -78.19 Million |
| Effect of forex changes on cash | 3.28 Million | 6.55 Million | -1.28 Million | -1.35 Million | 1.83 Million | -1.53 Million |
| Net cash flow / Change in cash | -66.16 Million | 264.96 Million | -72.72 Million | -313.64 Million | 282.42 Million | 232.17 Million |
| Free Cash Flow | -146.76 Million | -180.19 Million | -290.45 Million | -285.29 Million | -288.66 Million | -255.03 Million |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 31.55 Million | -22.59 Million | -37.75 Million | -15.16 Million | -50.04 Million | -34.19 Million |
| Depreciation & Amortization | 30.57 Million | 24.35 Million | 43.02 Million | 17.82 Million | 38.03 Million | 18.54 Million |
| Deferred income taxes | - | - | - | - | 7.34 Million | 42.28 Million |
| Stock-based compensation | - | 10.64 Million | 10.64 Million | - | 16.11 Million | 16.11 Million |
| Change in working capital | - | -92.5 Million | 11.72 Million | - | 44.14 Million | -40.58 Million |
| Other non-cash items | -34.32 Million | 74.12 Million | 2.2 Million | 59.74 Million | 4.33 Million | 71.2 Million |
| Investing Cash Flow | -68.78 Million | -79.35 Million | -164.1 Million | -84.74 Million | -282.76 Million | -219.35 Million |
| Investments in PPE | -68.85 Million | -71.5 Million | -203.2 Million | -125.77 Million | -240.12 Million | -181.1 Million |
| Acquisitions | - | - | -2.6 Million | -3.81 Million | -5.15 Million | 94 Thousand |
| Investment purchases | - | - | -280 Million | -320.05 Million | -255 Million | -279.91 Million |
| Sales/Maturities of investments | - | - | 321.21 Million | 366.67 Million | 215.63 Million | 241.95 Million |
| Other Investing Activities | 69 Thousand | -7.85 Million | 33.17 Million | 41.02 Million | 1.87 Million | -38.24 Million |
| Financing Cash Flow | 36.2 Million | 4.13 Million | 38.22 Million | 34.08 Million | 481.24 Million | 447.85 Million |
| Debt repayment | -37.73 Million | - | -56.65 Million | -39.64 Million | -196.19 Million | -44.77 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | 405.78 Million | 453.98 Million |
| Other Financing Activities | -1.53 Million | 4.13 Million | -3.37 Million | -5.56 Million | 271.64 Million | 447.85 Million |
| Accounts receivables | - | -82.54 Million | -82.54 Million | - | -35.68 Million | -36.27 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | -31.18 Million | -31.18 Million | - | -65.26 Million | -65.26 Million |
| Other working capital | - | 21.22 Million | 21.22 Million | - | 145.08 Million | 60.95 Million |
| Cash at beginning of period | 351.6 Million | 432.97 Million | 417.76 Million | 472.41 Million | 152.8 Million | 154.87 Million |
| Cash at end of period | 348.35 Million | 432.97 Million | 351.6 Million | 432.97 Million | 417.76 Million | 472.41 Million |
| Capital Expenditure | -68.85 Million | -71.5 Million | -203.2 Million | -125.77 Million | -240.12 Million | -181.1 Million |
| Effect of forex changes on cash | 1.52 Million | -176 Thousand | 3.28 Million | 3.45 Million | 6.55 Million | 3.31 Million |
| Net cash flow / Change in cash | -3.25 Million | - | -66.16 Million | -39.43 Million | 264.96 Million | 317.53 Million |
| Free Cash Flow | -41.05 Million | -77.48 Million | -146.76 Million | -63.36 Million | -180.19 Million | -150.03 Million |
EBTC
HUBN
BZWR
002229
DEXP4
SWTQ